Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer patients.
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2017
At a glance
- Drugs Epirubicin (Primary)
- Indications Advanced breast cancer
- Focus Diagnostic use
- 09 Jun 2017 According to a Medical Prognosis Institute media release, data from this trial presented at the 2017 Annual meeting of American Society of Clinical Oncology (ASCO).
- 09 Jun 2017 New trial record
- 04 Jun 2017 Results (n=137) from this trial published in a Medical Prognosis Institute Media Release.